stella
beta
A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy — Stella
Recruiting
Back to Multiple System Atrophy - Parkinsonian Subtype (MSA-P) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov